Key result
Soluble ST2 linked to ~20.1-fold higher 30-day mortality, outperforming high-sensitivity troponin.
Why the study?
Does soluble ST2 (sST2) measured at emergency department arrival better predict 30-day mortality compared with high-sensitivity cardiac troponin I (hs-cTnI) in patients presenting with chest pain?
Cohort (n=157)
No
Does soluble ST2 (sST2) measured at emergency department arrival better predict 30-day mortality compared with high-sensitivity cardiac troponin I (hs-cTnI) in patients presenting with chest pain?
Answers are grounded in this paper and cite their sources.
In patients presenting to the emergency department with chest pain, soluble ST2 measured at arrival is a stronger independent predictor of 30-day cardiac mortality than high-sensitivity troponin I, particularly in STEMI patients with levels >35 ng/mL.
BACKGROUND: High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS). The aim of this study was to test the short term prognostic value of sST2 compared with hs-cTnI in patients with chest pain. METHODS: Assays for hs-cTnI and sST2 were performed in 157 patients admitted to the Emergency Department (ED) for chest pain at arrival. In-hospital and 30-day follow-up mortalities were assessed. RESULTS: The incidence of ACS was 37%; 33 patients were diagnosed with ST elevation myocardial infarction (STEMI), and 25 were diagnosed with non-ST elevation myocardial infarction (NSTEMI). Compared with the no acute coronary syndrome (NO ACS) group, the median level of hs-cTnI was higher in ACS patients: 7.22 (5.24-14) pg/mL vs 68 (15.33-163.50) pg/mL (P<0.0001). In all patients, the sST2 level at arrival showed higher independent predictive power than hs-cTnI (odds ratio [OR] 20.13, P<0.0001 and OR 2.61, P<0.0008, respectively). sST2 at ED arrival showed a greater prognostic value for cardiovascular events in STEMI (area under the curve [AUC] 0.80, P<0.001) than NSTEMI patients (AUC 0.72, P<0.05). Overall, 51% of the STEMI patients with an sST2 value>35 ng/mL at ED arrival died during the 30-day follow-up. CONCLUSIONS: sST2 has a greater prognostic value for 30-day cardiac mortality after discharge in patients presenting to the ED for chest pain compared with hs-cTnI. In STEMI patients, an sST2 value >35 ng/mL at ED arrival showed the highest predictive power for short-term mortality.
No takes yet. Share an insight, caveat, or question.
Marino et al. (2016) conducted a cohort in Chest pain and suspected acute coronary syndrome (n=157). Soluble suppression of tumorigenicity 2 (sST2) level at ED arrival vs. High-sensitivity cardiac troponin I (hs-cTnI) level at ED arrival was evaluated on 30-day mortality (OR 20.13, 95% CI 4.85-83.47, p=<0.0001). Soluble ST2 at emergency department arrival showed higher independent predictive power for 30-day mortality than high-sensitivity troponin I.
Synapse has enriched 10 related papers. Consider them for comparative context: